Literature DB >> 28008454

Intra-arterial contrast-enhanced ultrasound (IA CEUS) for localization of hepatocellular carcinoma (HCC) supply during transarterial chemoembolization (TACE): a case series.

Ilya Lekht1, Megha Nayyar1, Brian Luu1, Phillip L Guichet2, Jessica Ho1, Ramon Ter-Oganesyan1, Michael Katz1, Mittul Gulati1.   

Abstract

Transarterial chemoembolization (TACE) is a proven catheter-based locoregional therapy for treatment of hepatocellular carcinoma (HCC). Drug-eluting bead TACE involves delivering micrometer-sized particles preloaded with doxorubicin directly to the tumor via its arterial blood supply and results in vascular embolization with intra-tumoral drug release. Effective therapy requires mapping of the tumor arterial supply, which in some cases cannot be accomplished with conventional angiographic techniques alone. Contrast-enhanced ultrasound (CEUS) is an imaging technique which utilizes microbubble contrast agents to demonstrate blood flow and tissue perfusion, enabling tumor visualization in real time. CEUS with intravenous contrast administration is well established for evaluation of HCC. Intra-arterial (IA) CEUS, on the other hand, is an emerging technique that allows more selective evaluation of the arterial supply to the tumor. The three cases in this report illustrate the utility of intra-procedural IA CEUS during TACE. Specifically, IA CEUS aided TACE in cases where the HCC showed poor arterial enhancement, an extrahepatic arterial supply, and a portal venous supply, respectively.

Entities:  

Keywords:  Contrast-enhanced ultrasound; Hepatocellular carcinoma; Intra-arterial contrast-enhanced ultrasound; Transarterial chemoembolization

Mesh:

Substances:

Year:  2017        PMID: 28008454     DOI: 10.1007/s00261-016-1016-0

Source DB:  PubMed          Journal:  Abdom Radiol (NY)


  4 in total

Review 1.  Contrast-enhanced ultrasound (CEUS) in HCC diagnosis and assessment of tumor response to locoregional therapies.

Authors:  John R Eisenbrey; Helena Gabriel; Esika Savsani; Andrej Lyshchik
Journal:  Abdom Radiol (NY)       Date:  2021-04-07

2.  Efficacy of intra-arterial contrast-enhanced ultrasonography during transarterial chemoembolization with drug-eluting beads for hepatocellular carcinoma.

Authors:  Kazue Shiozawa; Manabu Watanabe; Takashi Ikehara; Shuhei Yamamoto; Takashi Matsui; Yoshinori Saigusa; Yoshinori Igarashi; Iruru Maetani
Journal:  World J Hepatol       Date:  2018-01-27

3.  The value of intra-procedural transcatheter intraarterial contrast-enhanced ultrasonography (IA-CEUS) in predicting the short-term efficacy of conventional transarterial chemoembolization (cTACE).

Authors:  Xiang Fei; Zhi-Jun Wang; Ye Li; Peng Han; Xiao-Hui Li; Bo Jiang
Journal:  Transl Cancer Res       Date:  2020-05       Impact factor: 1.241

4.  Intraarterial contrast-enhanced ultrasound to predict the short-term tumour response of hepatocellular carcinoma to Transarterial chemoembolization with Lipiodol.

Authors:  Jiang Bo; Han Peng; Zhu LianHua; Fei Xiang; Luo YuKun
Journal:  BMC Cancer       Date:  2021-11-02       Impact factor: 4.430

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.